Systems and apparatuses for administering reduced pressure treatment to a tissue site include a reduced pressure source, a drape having a plurality of projections for contacting the tissue site, and an adhesive connected to at least a portion of the drape for sealing the drape to a portion of a patient's intact epidermis.

The disclosure relates to a device for vaginal drug delivery. More particularly, the device relates to a tampon engaged or engageable device, having a dissolvable elongated housing which is adapted with an axial cavity sized to surround a tampon, and having a fixed or removably engaged dissolvable capsule located at a distal end of the housing. So positioned, the device delivers medications such as prescription and non prescription drugs, neuroceuticals, and supplements and the like, directly to the vaginal tract which is especially useful in treating ailments in the same region by such a direct communication of the medication thereto.

An absorbent member (4) of the present invention includes fiber clusters (11) containing synthetic fibers (11F) and includes water absorbing fibers (12F), and a plurality of the fiber clusters (11) are interlaced with each other or with the water absorbing fibers (12F). The content mass ratio of the fiber clusters (11) to the water absorbing fibers (12F) (fiber cluster ratio) is smaller in the side of a skin-facing surface (the side of a topsheet (2)) than in the side of a non-skin-facing surface (the side of a backsheet (3)) of the absorbent member (4). The fiber cluster (11) includes a main portion (110) formed by two opposite base surfaces (111) and a body surface (112) intersecting the base surfaces (111).

A method of diagnosis or prediction of infection of a mammalian wound, said method comprising the step of detecting the presence of a cytokine selected from the group comprising procalcitonin, amino procalcitonin (N-ProCT), eotaxin, granulocyte macrophage colony stimulating factor (GM-CSF), interleukins IB monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1a), regulated upon activation normal T expressed and secreted (RANTES) in fluid taken from the wound. Also claimed is the device for use in the method.

The present invention relates to wound dressings for use in cases of a patient suffering a penetrating chest trauma. The wound dressing comprises a base layer having a lower surface facing the wound and an upper surface facing away from the wound, and an aperture therethrough for locating over the wound, and a top layer extending over the aperture and at least a part of the upper surface. The base layer is connected to the top layer such that the wound dressing can transition from an open configuration in which the aperture and an area external to the wound dressing are in fluid communication via at least one opening at a perimeter between the base layer and the top layer, to a closed configuration in which the top layer forms a seal over the aperture.

The present invention relates to wound dressings for use in cases of a patient suffering a penetrating chest trauma. The wound dressing comprises a base layer having a lower surface facing the wound and an upper surface facing away from the wound, and an aperture therethrough for locating over the wound, and a top layer extending over the aperture and at least a part of the upper surface. The base layer is connected to the top layer such that the wound dressing can transition from an open configuration in which the aperture and an area external to the wound dressing are in fluid communication via at least one opening at a perimeter between the base layer and the top layer, to a closed configuration in which the top layer forms a seal over the aperture.

The present application provides a negative pressure wound dressing, including foam and a bio-cellulose film with a three-dimensional reticular structure formed on a surface of the foam, wherein a projected area of the bio-cellulose film on a bonding surface of the foam and the bio-cellulose film is greater than or equal to that of the foam. The presence of the bio-cellulose film between the foam and a wound avoids the foam from sticking to the wound and the growth of new tissue into the foam when performing a negative pressure wound therapy. Also, when replacing the foam, a secondary damage to the wound is reduced, so as to relieve pain that the patient suffers.

The present application provides a negative pressure wound dressing, including foam and a bio-cellulose film with a three-dimensional reticular structure formed on a surface of the foam, wherein a projected area of the bio-cellulose film on a bonding surface of the foam and the bio-cellulose film is greater than or equal to that of the foam. The presence of the bio-cellulose film between the foam and a wound avoids the foam from sticking to the wound and the growth of new tissue into the foam when performing a negative pressure wound therapy. Also, when replacing the foam, a secondary damage to the wound is reduced, so as to relieve pain that the patient suffers.

Odor control articles (10) including hydrophobic polymers of intrinsic porosity (HPIM) and their use in personal care products and hygienic products is disclosed. The odor control article (10) includes a HPIM and a colorant. The odor control article (10) may be applied to a substrate (11), and more specifically to a liquid absorbent member (30), to form an odor-absorbing member (20). The substrate (11) may absorb liquid. The odor-absorbing member (20) may be placed in such products as diapers (200), incontinence pads (60) and refrigerator pads. A method of making an odor control suspension with HPIMs including the use of surfactants is also disclosed. The odor control suspension may also be applied to a substrate (11).

Odor control articles (10) including hydrophobic polymers of intrinsic porosity (HPIM) and their use in personal care products and hygienic products is disclosed. The odor control article (10) includes a HPIM and a colorant. The odor control article (10) may be applied to a substrate (11), and more specifically to a liquid absorbent member (30), to form an odor-absorbing member (20). The substrate (11) may absorb liquid. The odor-absorbing member (20) may be placed in such products as diapers (200), incontinence pads (60) and refrigerator pads. A method of making an odor control suspension with HPIMs including the use of surfactants is also disclosed. The odor control suspension may also be applied to a substrate (11).